$TBPH Theravance Biopharma, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Theravance Biopharma, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Theravance Biopharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Theravance Biopharma, Inc. for free.

CIK Number: 0001583107
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TBPH
Company Address: UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN KY1-1104

Theravance Biopharma, Inc. operates as a biopharmaceutical company, which focuses on the discovery, development and commercialization of small molecule medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Market Capitalization: $1.64B
Prev close: $30.60
Average Daily Volume: 346,635
Days Low: $30.63
Year Low: $13.59
Year High: $38.92

Theravance Biopharma, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
GALA RENEE DSVP, Chief Financial Officer157,6574,824,304shares bought: 132,750 / shares sold: -136,488 SELLNov 21 20183 months ago
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc199,9116,117,277shares bought: 245,000 / shares sold: -128,347 STRONG BUYFeb 07 201910 days ago
HEGDE SHARATHCHANDRA SSVP, Research229,9977,037,908shares bought: 260,000 / shares sold: -63,918 STRONG BUYFeb 07 201910 days ago
PASQUALONE FRANKSVP, Chief Comm Ops Officer281,3408,609,004shares bought: 249,000 / shares sold: -60,857 STRONG BUYFeb 07 201910 days ago
PITZER KENNETH RSVP, Prod Strat & Comm Plng223,0746,826,064shares bought: 269,000 / shares sold: -62,237 STRONG BUYFeb 07 201910 days ago
Shafer Bradford JEVP, Gen. Counsel, Secretary141,9944,345,016shares bought: 279,000 / shares sold: -230,191 BUYFeb 07 201910 days ago
Winningham Rick EChief Executive Officer965,93929,557,733shares bought: 768,000 / shares sold: -168,820 STRONG BUYFeb 07 201910 days ago
WORBOYS PHILIP DSVP, Translational Science227,3806,957,828shares bought: 269,000 / shares sold: -73,582 STRONG BUYFeb 07 201910 days ago

View all Theravance Biopharma, Inc. insiders.

Theravance Biopharma, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 07 2019TBPHTheravance Biophar ...WORBOYS PHILIP DSVP, Translational ...GrantA0.0047,2500274,630227.4 K to 274.6 K (+20.78 %)
Feb 07 2019TBPHTheravance Biophar ...WORBOYS PHILIP DSVP, Translational ...GrantA0.0065,0000227,380162.4 K to 227.4 K (+40.03 %)
Feb 07 2019TBPHTheravance Biophar ...Winningham Rick EChief Executive Off ...GrantA0.00147,00001,112,939965.9 K to 1.1 M (+15.22 %)
Feb 07 2019TBPHTheravance Biophar ...Winningham Rick EChief Executive Off ...GrantA0.00170,0000965,939795.9 K to 965.9 K (+21.36 %)
Feb 07 2019TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...GrantA0.0047,2500189,244142 K to 189.2 K (+33.28 %)
Feb 07 2019TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...GrantA0.0065,0000141,99477 K to 142 K (+84.42 %)
Feb 07 2019TBPHTheravance Biophar ...PITZER KENNETH RSVP, Prod Strat & C ...GrantA0.0047,2500270,324223.1 K to 270.3 K (+21.18 %)
Feb 07 2019TBPHTheravance Biophar ...PITZER KENNETH RSVP, Prod Strat & C ...GrantA0.0065,0000223,074158.1 K to 223.1 K (+41.12 %)
Feb 07 2019TBPHTheravance Biophar ...PASQUALONE FRANKSVP, Chief Comm Ops ...GrantA0.0047,2500328,590281.3 K to 328.6 K (+16.79 %)
Feb 07 2019TBPHTheravance Biophar ...PASQUALONE FRANKSVP, Chief Comm Ops ...GrantA0.0065,0000281,340216.3 K to 281.3 K (+30.05 %)
Feb 07 2019TBPHTheravance Biophar ...HEGDE SHARATHCHANDRA SSVP, ResearchGrantA0.0047,2500277,247230 K to 277.2 K (+20.54 %)
Feb 07 2019TBPHTheravance Biophar ...HEGDE SHARATHCHANDRA SSVP, ResearchGrantA0.0065,0000229,997165 K to 230 K (+39.39 %)
Feb 07 2019TBPHTheravance Biophar ...HAUMANN BRETT KSVP Clin Dev & Chie ...GrantA0.0047,2500247,161199.9 K to 247.2 K (+23.64 %)
Feb 07 2019TBPHTheravance Biophar ...HAUMANN BRETT KSVP Clin Dev & Chie ...GrantA0.0065,0000199,911134.9 K to 199.9 K (+48.18 %)
Nov 21 2018TBPHTheravance Biophar ...WORBOYS PHILIP DSVP, Translational ...Payment of ExerciseF24.794,373108,407162,380166.8 K to 162.4 K (-2.62 %)

View all Theravance Biopharma, Inc. insider transactions.